Patent details

EP2608809 Title: ANTIBODIES TO MATRIX METALLOPROTEINASE 9

Basic Information

Publication number:
EP2608809
PCT Application Number:
US2011049448
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118207596
PCT Publication Number:
WO2012027721
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES TO MATRIX METALLOPROTEINASE 9
French Title of Invention:
ANTICORPS CONTRE LA MÉTALLOPROTÉINASE DE MATRICE 9
German Title of Invention:
ANTIKÖRPER GEGEN MATRIX-METALLOPROTEINASE-9
SPC Number:

Dates

Filing date:
26/08/2011
Grant date:
22/05/2019
EP Publication Date:
03/07/2013
PCT Publication Date:
01/03/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/05/2019
EP B1 Publication Date:
22/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/08/2019
Expiration date:
26/08/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/05/2019
 
 

Name:
Gilead Biologics, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
MCCAULEY, Scott Alan
Address:
United States (US)

2

Name:
VAYSBERG, Maria
Address:
United States (US)

Priority

Priority Number:
377886 P
Priority Date:
27/08/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 16/40; C12P 21/08;

Publication

European Patent Bulletin

Issue number:
201921
Publication date:
22/05/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages